Manufacturing for the future
Technologies for bioprocessing and cell therapy manufacturing are pushing boundaries. Risk reduction and speed to market are critical parameters to reach success. To support the evolving business climate, we provide a range of innovative, flexible solutions that blend platforms and facilities with services and expertise.
Meeting unique needs
Enterprise solutions is our end-to-end platform that is transforming biomanufacturing with powerful and innovative modular approaches. Bioprocessing and cell therapy manufacturers are looking for new options to achieve flexibility and efficiency. Discover how Cytiva's proven enterprise solutions address the complexity of biomanufacturing.BIOPROCESSINGCELL THERAPY
FlexFactory configurable platform
Futureproof your manufacturing strategy with flexible technologies. FlexFactory provides a seamless single-use or hybrid platform to support scale-up or scale-out processes. Platforms can be configured to suit your unique bioprocessing or cell therapy manufacturing needs. Your FlexFactory platform can be up and running in 12 months.
KUBio prefabricated manufacturing facility
KUBio dramatically reduces risk and time to market compared with traditional stick-built facilities. KUBio features pre-engineered manufacturing modules, which are produced in parallel then assembled and qualified on-site. As a result, your KUBio, which includes one or more FlexFactory platforms, can be operational in 18 -20 months.